Early- or adult-onset obesity has a similar cardiometabolic profile and weight loss response to clinical treatment in adulthood

Q2 Medicine Obesity Medicine Pub Date : 2023-03-01 DOI:10.1016/j.obmed.2022.100475
Marta Germano Prado , Patrícia Teófilo Monteagudo , Glaucia Carneiro , Maria Teresa Zanella , Bianca de Almeida-Pititto
{"title":"Early- or adult-onset obesity has a similar cardiometabolic profile and weight loss response to clinical treatment in adulthood","authors":"Marta Germano Prado ,&nbsp;Patrícia Teófilo Monteagudo ,&nbsp;Glaucia Carneiro ,&nbsp;Maria Teresa Zanella ,&nbsp;Bianca de Almeida-Pititto","doi":"10.1016/j.obmed.2022.100475","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.</p></div><div><h3>Methods</h3><p>A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.</p></div><div><h3>Results</h3><p>Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) <em>vs.</em> 47.9(10.5) years, p &lt; 0.001] and presented a higher frequency of BMI≥40kg/m<sup>2</sup> [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.</p></div><div><h3>Conclusions</h3><p>Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847622000872","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.

Methods

A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.

Results

Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) vs. 47.9(10.5) years, p < 0.001] and presented a higher frequency of BMI≥40kg/m2 [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.

Conclusions

Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
早期或成年发病的肥胖对成年临床治疗有相似的心脏代谢特征和体重减轻反应
目的:我们旨在评估肥胖成年人生命周期中肥胖发作期与其心脏代谢状况和临床治疗反应之间的关系。方法对124名≥18岁的肥胖患者进行横断面研究,这些患者根据相同的护理方案接受肥胖临床治疗,并根据儿童/青少年(早期)或成年(成年)的肥胖发病期进行分层。比较各组的心脏代谢状况(如高血压、血脂异常和糖尿病)和临床治疗期间的体重减轻(平均随访2年)。基线体重减轻≥10%被认为是对临床治疗的成功反应。结果早发性肥胖组(n=40)在随访开始时更年轻[35.8(10.3)vs.47.9(10.5)岁,p<;0.001],BMI≥40kg/m2的频率高于成人期肥胖组(n=84)[29(72.5)vs.42(50.0)%,p=0.018)]。两组的肥胖持续时间和随访时间相似,治疗期间的平均体重减轻以及高血压、糖尿病、糖尿病前期或血脂异常的频率相似。结论早期和成人肥胖患者对肥胖临床治疗的减肥反应以及心脏代谢危险因素的患病率相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Obesity Medicine
Obesity Medicine Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍: The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.
期刊最新文献
Sorghum bicolor polyphenol-rich extract improves insulin sensitivity and protect against chronic stress exacerbated diabetic nephropathy through modulation of Nrf2/NF-κB Swimming exercise regulates indices of skeletal muscle glucose metabolism and attenuates cardiac inflammatory cytokines activity via IL-6/TNF-α pathway in streptozotocin-induced diabetic rats Sestrin2 at the crossroads of cardiovascular disease and diabetes: A comprehensive review Three scientists on GLP-1 based obesity drug development are sharing 2024 Lasker-DeBakey Clinical Research Award Erratum to “Effect of low-calorie ketogenic vs low-carbohydrate diets on body composition and other biomarkers of overweight/obese women: An 8 weeks randomised controlled trial” [Obes. Med. 41C (2023) 100496]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1